Investigation of retinal nerve fiber layer thickness in patients with neurofibromatosis-1

Purpose To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls. Methods Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study....

Full description

Saved in:
Bibliographic Details
Published inJapanese journal of ophthalmology Vol. 58; no. 2; pp. 172 - 176
Main Authors Topcu-Yilmaz, Pinar, Kasim, Burcu, Kiratli, Hayyam
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.03.2014
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0021-5155
1613-2246
1613-2246
DOI10.1007/s10384-014-0308-6

Cover

Abstract Purpose To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls. Methods Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups. Results The average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 μm) than in the controls (108.89 ± 9.92 μm) and NF-1 patients without OPGs (111.17 ± 12.13 μm) ( p  < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm 3 ) than in the healthy controls (7.19 ± 0.36 mm 3 ; p  = 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm 3 ; p  = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA. Conclusion The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients.
AbstractList Purpose To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls. Methods Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups. Results The average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 μm) than in the controls (108.89 ± 9.92 μm) and NF-1 patients without OPGs (111.17 ± 12.13 μm) ( p  < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm 3 ) than in the healthy controls (7.19 ± 0.36 mm 3 ; p  = 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm 3 ; p  = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA. Conclusion The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients.
Purpose: To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls. Methods: Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups. Results: The average RNFL thickness was significantly lower in the OPG group (76.72 plus or minus 22.16 mu m) than in the controls (108.89 plus or minus 9.92 mu m) and NF-1 patients without OPGs (111.17 plus or minus 12.13 mu m) (p < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 plus or minus 0.66 mm super(3)) than in the healthy controls (7.19 plus or minus 0.36 mm super(3); p = 0.001) and NF-1 patients without OPGs (7.25 plus or minus 0.26 mm super(3); p = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA. Conclusion: The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients.
To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls. Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups. The average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 μm) than in the controls (108.89 ± 9.92 μm) and NF-1 patients without OPGs (111.17 ± 12.13 μm) (p < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm(3)) than in the healthy controls (7.19 ± 0.36 mm(3); p = 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm(3); p = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA. The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients.
To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls.PURPOSETo compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls.Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups.METHODSTen patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups.The average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 μm) than in the controls (108.89 ± 9.92 μm) and NF-1 patients without OPGs (111.17 ± 12.13 μm) (p < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm(3)) than in the healthy controls (7.19 ± 0.36 mm(3); p = 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm(3); p = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA.RESULTSThe average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 μm) than in the controls (108.89 ± 9.92 μm) and NF-1 patients without OPGs (111.17 ± 12.13 μm) (p < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm(3)) than in the healthy controls (7.19 ± 0.36 mm(3); p = 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm(3); p = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA.The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients.CONCLUSIONThe results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients.
To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy controls. Ten patients with NF-1, 17 patients with NF-1-associated OPGs, and 17 control subjects were included in the study. Retinal nerve fiber layer (RNFL) and macular thickness findings measured with Stratus OCT were compared between the groups. The average RNFL thickness was significantly lower in the OPG group (76.72 ± 22.16 [mu]m) than in the controls (108.89 ± 9.92 [mu]m) and NF-1 patients without OPGs (111.17 ± 12.13 [mu]m) (p < 0.001). The macular volume was also found to be lower in NF-1 patients with OPG (6.41 ± 0.66 mm^sup 3^) than in the healthy controls (7.19 ± 0.36 mm^sup 3^; p = 0.001) and NF-1 patients without OPGs (7.25 ± 0.26 mm^sup 3^; p = 0.005). Following this analysis the OPG group was further subdivided into two categories: OPG patients with normal visual acuity (VA) and OPG patients with decreased VA. The statistical analysis was repeated for these four subgroups, revealing that while the decrement in the average RNFL thickness was significant for both OPG groups that in the macular volume was only significant for OPG patients with decreased VA. The results of our study suggest that RNFL thinning can be a helpful marker for the detection of OPGs in NF-1 patients. Larger studies with longitudinal data are required to confirm the role of OCT in the diagnosis and follow-up of these patients.[PUBLICATION ABSTRACT]
Author Kasim, Burcu
Kiratli, Hayyam
Topcu-Yilmaz, Pinar
Author_xml – sequence: 1
  givenname: Pinar
  surname: Topcu-Yilmaz
  fullname: Topcu-Yilmaz, Pinar
  organization: Department of Ophthalmology, Konya Training and Research Hospital
– sequence: 2
  givenname: Burcu
  surname: Kasim
  fullname: Kasim, Burcu
  organization: Department of Ophthalmology, Hacettepe University School of Medicine
– sequence: 3
  givenname: Hayyam
  surname: Kiratli
  fullname: Kiratli, Hayyam
  email: hkiratli@hacettepe.edu.tr
  organization: Department of Ophthalmology, Hacettepe University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24488155$$D View this record in MEDLINE/PubMed
BookMark eNqNkUFvFSEQx4mpsa-tH8CL2cRLL6vMAMvu0TRamzTpRQ89EZY321L3wRPYmn57aV81pommByCZ_H4MzP-A7YUYiLE3wN8D5_pDBi562XKoS_C-7V6wFXQgWkTZ7bEV5witAqX22UHON5xziQJfsX2Usu9rfcUuz8It5eKvbPExNHFqEhUf7NwESrfUTH6k1Mz2ru7l2rvvgXJufGi2VaBQcvPTl-sKLylWNsWNLTH73MIReznZOdPrx_OQffv86evJl_b84vTs5ON56yQOpRXr0WnsHAfnpFW8tzCSRhwV9hNf2zUp0iBqBaSybpisUCBwUqhRg0VxyI53925T_LHUv5iNz47m2QaKSzagpBiGbuDPQbnWg-yFqui7J-hNXFKdywPVaUDoRaXePlLLuKG12Sa_senO_J5vBWAHuBRzTjT9QYCb-wzNLkNTMzT3GZquOvqJ43x5iKck6-f_mrgzc-0Srij99eh_Sr8AFRGuZw
CitedBy_id crossref_primary_10_1111_aos_14755
crossref_primary_10_1080_02713683_2017_1408130
crossref_primary_10_1080_01658107_2023_2276189
crossref_primary_10_1007_s00381_017_3578_8
crossref_primary_10_1016_j_jfo_2021_08_012
crossref_primary_10_1371_journal_pone_0305548
crossref_primary_10_1038_s41598_024_71832_2
crossref_primary_10_1097_IAE_0000000000000650
crossref_primary_10_1097_WNO_0000000000001241
crossref_primary_10_1007_s00417_018_4007_8
crossref_primary_10_1016_j_survophthal_2017_10_007
crossref_primary_10_1080_13816810_2023_2245464
crossref_primary_10_1007_s10792_016_0412_3
crossref_primary_10_1080_13816810_2020_1849315
crossref_primary_10_3389_fneur_2018_01102
Cites_doi 10.1093/neuonc/nos076
10.1001/archopht.119.4.516
10.1002/ana.410410204
10.1097/WNO.0b013e31822aef82
10.1016/S1474-4422(06)70573-7
10.1016/S0022-3476(95)70159-1
10.1016/S0002-9394(00)00852-7
10.1097/ICU.0b013e3283313d4e
10.1167/iovs.06-0327
10.1016/S0887-8994(00)00230-7
10.1167/iovs.07-1127
10.1016/j.jaapos.2010.08.014
10.1002/ana.21107
10.1055/s-2008-1073043
10.1111/j.1444-0938.2007.00151.x
10.1016/j.ajo.2010.08.046
10.1016/j.jaapos.2006.02.004
10.1016/0887-8994(94)00110-N
10.1111/j.1442-9071.2009.02015.x
10.1016/j.ophtha.2005.10.040
10.1016/S0022-3476(94)70122-9
10.1016/0887-8994(95)90005-5
ContentType Journal Article
Copyright Japanese Ophthalmological Society 2014
Copyright_xml – notice: Japanese Ophthalmological Society 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7T7
7U9
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
C1K
CCPQU
FR3
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
7TK
DOI 10.1007/s10384-014-0308-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList
Neurosciences Abstracts
MEDLINE
MEDLINE - Academic
Technology Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1613-2246
EndPage 176
ExternalDocumentID 3244483451
24488155
10_1007_s10384_014_0308_6
Genre Journal Article
Comparative Study
Observational Study
GroupedDBID ---
--K
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
1B1
1N0
1~5
203
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
3V.
4.4
406
408
409
40D
40E
4G.
53G
5GY
5VS
67Z
6NX
7-5
7.U
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAEDT
AAHNG
AAIAL
AAJBT
AAJKR
AALRI
AANXM
AANZL
AAQFI
AAQXK
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAXUO
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABWVN
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACIUM
ACKNC
ACMDZ
ACMLO
ACNCT
ACOKC
ACOMO
ACPIV
ACPRK
ACRPL
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADMUD
ADNMO
ADPHR
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FDB
FEDTE
FERAY
FFXSO
FGOYB
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HLICF
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LLZTM
M1P
M41
M4Y
MA-
N2Q
NB0
NPVJJ
NQ-
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOR
QOS
R2-
R89
R9I
RIG
ROL
RPX
RPZ
RRX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SDM
SEW
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
SSZ
STPWE
SV3
SZ9
SZN
T13
TKC
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
X7J
X7M
YLTOR
Z45
Z7U
Z87
ZGI
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEUPX
AEZWR
AFDZB
AFHIU
AFOHR
AFPUW
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T7
7U9
7XB
8FD
8FK
C1K
FR3
H94
K9.
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
7TK
ID FETCH-LOGICAL-c429t-3dbc726c01cc4a508a1be722b528f0dade5e713722145ac9fa35132f527271a23
IEDL.DBID U2A
ISSN 0021-5155
1613-2246
IngestDate Thu Oct 02 10:22:29 EDT 2025
Wed Oct 01 12:43:49 EDT 2025
Fri Oct 03 09:21:58 EDT 2025
Thu Apr 03 07:01:04 EDT 2025
Wed Oct 01 04:37:12 EDT 2025
Thu Apr 24 23:08:16 EDT 2025
Fri Feb 21 02:35:03 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Optic pathway glioma
Optical coherence tomography
Retinal nerve fiber layer thickness
Neurofibromatosis-1
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c429t-3dbc726c01cc4a508a1be722b528f0dade5e713722145ac9fa35132f527271a23
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
ObjectType-Undefined-3
PMID 24488155
PQID 1506712183
PQPubID 34516
PageCount 5
ParticipantIDs proquest_miscellaneous_1543996902
proquest_miscellaneous_1507794835
proquest_journals_1506712183
pubmed_primary_24488155
crossref_primary_10_1007_s10384_014_0308_6
crossref_citationtrail_10_1007_s10384_014_0308_6
springer_journals_10_1007_s10384_014_0308_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-03-01
PublicationDateYYYYMMDD 2014-03-01
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationSubtitle The Official English-Language Journal of the Japanese Ophthalmological Society
PublicationTitle Japanese journal of ophthalmology
PublicationTitleAbbrev Jpn J Ophthalmol
PublicationTitleAlternate Jpn J Ophthalmol
PublicationYear 2014
Publisher Springer Japan
Springer Nature B.V
Publisher_xml – name: Springer Japan
– name: Springer Nature B.V
References Wolsey, Larson, Creel, Hoffman (CR17) 2006; 10
Subei, Eggenberger (CR11) 2009; 20
Avery, Liu, Fisher, Quinn, Belasco, Phillips (CR12) 2011; 151
Balcer, Liu, Heller, Bilaniuk, Volpe, Galetta (CR6) 2001; 131
Danesh-Meyer, Carroll, Foroozan, Savino, Fan, Jiang (CR19) 2006; 47
Sakata, Deleon-Ortega, Sakata, Girkin (CR10) 2009; 37
Listernick, Louis, Packer, Gutmann (CR8) 1997; 41
Listernick, Charrow, Greenwald, Mets (CR3) 1994; 125
Frohman, Costello, Zivadinov, Stuve, Conger, Winslow (CR22) 2006; 5
Parsa, Hoyt, Lesser, Weinstein, Strother, Muci-Mendoza (CR7) 2001; 119
Chen, Lee (CR9) 2007; 90
Liu, Malloy, Needle, Phillips (CR18) 1995; 12
Fisher, Jacobs, Markowitz, Galetta, Volpe, Nano-Schiavi (CR21) 2006; 113
Augsburger, Bolling, Yanoff, Duker (CR1) 2004
Listernick, Ferner, Liu, Gutmann (CR2) 2007; 61
Fisher, Loguidice, Gutmann, Listernick, Ferner, Ullrich (CR15) 2012; 14
Danesh-Meyer, Papchenko, Savino, Law, Evans, Gamble (CR20) 2008; 49
Avery, Fisher, Liu (CR14) 2011; 31
Kuenzle, Weissert, Roulet, Bode, Schefer, Huisman (CR4) 1994; 25
Chang, El-Dairi, Frempong, Burner, Bhatti, Young (CR13) 2010; 14
Listernick, Darling, Greenwald, Strauss, Charrow (CR5) 1995; 127
Ng, North (CR16) 2001; 24
R Listernick (308_CR3) 1994; 125
GT Liu (308_CR18) 1995; 12
BC Kuenzle (308_CR4) 1994; 25
HV Danesh-Meyer (308_CR20) 2008; 49
R Listernick (308_CR5) 1995; 127
LM Sakata (308_CR10) 2009; 37
YT Ng (308_CR16) 2001; 24
DH Wolsey (308_CR17) 2006; 10
CF Parsa (308_CR7) 2001; 119
E Frohman (308_CR22) 2006; 5
AM Subei (308_CR11) 2009; 20
R Listernick (308_CR2) 2007; 61
RA Avery (308_CR14) 2011; 31
JJ Augsburger (308_CR1) 2004
HV Danesh-Meyer (308_CR19) 2006; 47
L Chang (308_CR13) 2010; 14
R Listernick (308_CR8) 1997; 41
RA Avery (308_CR12) 2011; 151
MJ Fisher (308_CR15) 2012; 14
JB Fisher (308_CR21) 2006; 113
LJ Balcer (308_CR6) 2001; 131
J Chen (308_CR9) 2007; 90
17697178 - Clin Exp Optom. 2007 Sep;90(5):317-35
11292406 - Am J Ophthalmol. 2001 Apr;131(4):442-5
7770126 - Neuropediatrics. 1994 Dec;25(6):295-300
21857190 - J Neuroophthalmol. 2011 Sep;31(3):269-78
17065494 - Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4827-35
19696668 - Curr Opin Ophthalmol. 2009 Nov;20(6):462-6
19338607 - Clin Exp Ophthalmol. 2009 Jan;37(1):90-9
7748370 - Pediatr Neurol. 1995 Jan;12(1):89-90
22474213 - Neuro Oncol. 2012 Jun;14(6):790-7
16406539 - Ophthalmology. 2006 Feb;113(2):324-32
7472822 - J Pediatr. 1995 Nov;127(5):718-22
16987732 - Lancet Neurol. 2006 Oct;5(10):853-63
16935228 - J AAPOS. 2006 Aug;10(4):307-11
21168074 - J AAPOS. 2010 Dec;14(6):511-7
11182280 - Pediatr Neurol. 2001 Jan;24(1):44-8
17387725 - Ann Neurol. 2007 Mar;61(3):189-98
21232732 - Am J Ophthalmol. 2011 Mar;151(3):542-9.e2
8021787 - J Pediatr. 1994 Jul;125(1):63-6
9029062 - Ann Neurol. 1997 Feb;41(2):143-9
11296017 - Arch Ophthalmol. 2001 Apr;119(4):516-29
18263812 - Invest Ophthalmol Vis Sci. 2008 May;49(5):1879-85
References_xml – volume: 14
  start-page: 790
  year: 2012
  end-page: 797
  ident: CR15
  article-title: Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/nos076
– start-page: 1097
  year: 2004
  ident: CR1
  article-title: Phakomatoses
  publication-title: Ophthalmology
– volume: 119
  start-page: 516
  year: 2001
  end-page: 529
  ident: CR7
  article-title: Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.119.4.516
– volume: 41
  start-page: 143
  year: 1997
  end-page: 149
  ident: CR8
  article-title: Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force
  publication-title: Ann Neurol
  doi: 10.1002/ana.410410204
– volume: 31
  start-page: 269
  year: 2011
  end-page: 278
  ident: CR14
  article-title: Optic pathway gliomas
  publication-title: J Neuro-ophthalmol
  doi: 10.1097/WNO.0b013e31822aef82
– volume: 5
  start-page: 853
  year: 2006
  end-page: 863
  ident: CR22
  article-title: Optical coherence tomography in multiple sclerosis
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(06)70573-7
– volume: 127
  start-page: 718
  year: 1995
  end-page: 722
  ident: CR5
  article-title: Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(95)70159-1
– volume: 131
  start-page: 442
  year: 2001
  end-page: 445
  ident: CR6
  article-title: Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(00)00852-7
– volume: 20
  start-page: 462
  year: 2009
  end-page: 466
  ident: CR11
  article-title: Optical coherence tomography: another useful tool in a neuro-ophthalmologist’s armamentarium
  publication-title: Curr Opin Ophthalmol
  doi: 10.1097/ICU.0b013e3283313d4e
– volume: 47
  start-page: 4827
  year: 2006
  end-page: 4835
  ident: CR19
  article-title: Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.06-0327
– volume: 24
  start-page: 44
  year: 2001
  end-page: 48
  ident: CR16
  article-title: Visual-evoked potentials in the assessment of optic gliomas
  publication-title: Pediatr Neurol
  doi: 10.1016/S0887-8994(00)00230-7
– volume: 49
  start-page: 1879
  year: 2008
  end-page: 1885
  ident: CR20
  article-title: In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for postchiasmal tumors
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.07-1127
– volume: 14
  start-page: 511
  year: 2010
  end-page: 517
  ident: CR13
  article-title: Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas
  publication-title: J AAPOS
  doi: 10.1016/j.jaapos.2010.08.014
– volume: 61
  start-page: 189
  year: 2007
  end-page: 198
  ident: CR2
  article-title: Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations
  publication-title: Ann Neurol
  doi: 10.1002/ana.21107
– volume: 25
  start-page: 295
  year: 1994
  end-page: 300
  ident: CR4
  article-title: Follow-up of optic pathway gliomas in children with neurofibromatosis type 1
  publication-title: Neuropediatrics
  doi: 10.1055/s-2008-1073043
– volume: 90
  start-page: 317
  year: 2007
  end-page: 335
  ident: CR9
  article-title: Clinical applications and new developments of optical coherence tomography: an evidence-based review
  publication-title: Clin Exp Optom
  doi: 10.1111/j.1444-0938.2007.00151.x
– volume: 151
  start-page: 542
  year: 2011
  end-page: 549
  ident: CR12
  article-title: Retinal nerve fiber layer thickness in children with optic pathway gliomas
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2010.08.046
– volume: 10
  start-page: 307
  year: 2006
  end-page: 311
  ident: CR17
  article-title: Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
  publication-title: J AAPOS
  doi: 10.1016/j.jaapos.2006.02.004
– volume: 12
  start-page: 89
  year: 1995
  end-page: 90
  ident: CR18
  article-title: Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials
  publication-title: Pediatr Neurol
  doi: 10.1016/0887-8994(94)00110-N
– volume: 37
  start-page: 90
  year: 2009
  end-page: 99
  ident: CR10
  article-title: Optical coherence tomography of the retina and optic nerve—a review
  publication-title: Clin Exp Ophthalmol
  doi: 10.1111/j.1442-9071.2009.02015.x
– volume: 113
  start-page: 324
  year: 2006
  end-page: 332
  ident: CR21
  article-title: Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2005.10.040
– volume: 125
  start-page: 63
  year: 1994
  end-page: 66
  ident: CR3
  article-title: Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(94)70122-9
– volume: 31
  start-page: 269
  year: 2011
  ident: 308_CR14
  publication-title: J Neuro-ophthalmol
  doi: 10.1097/WNO.0b013e31822aef82
– volume: 151
  start-page: 542
  year: 2011
  ident: 308_CR12
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2010.08.046
– volume: 5
  start-page: 853
  year: 2006
  ident: 308_CR22
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(06)70573-7
– volume: 131
  start-page: 442
  year: 2001
  ident: 308_CR6
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(00)00852-7
– volume: 14
  start-page: 511
  year: 2010
  ident: 308_CR13
  publication-title: J AAPOS
  doi: 10.1016/j.jaapos.2010.08.014
– volume: 90
  start-page: 317
  year: 2007
  ident: 308_CR9
  publication-title: Clin Exp Optom
  doi: 10.1111/j.1444-0938.2007.00151.x
– volume: 20
  start-page: 462
  year: 2009
  ident: 308_CR11
  publication-title: Curr Opin Ophthalmol
  doi: 10.1097/ICU.0b013e3283313d4e
– volume: 113
  start-page: 324
  year: 2006
  ident: 308_CR21
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2005.10.040
– volume: 127
  start-page: 718
  year: 1995
  ident: 308_CR5
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(95)70159-1
– volume: 24
  start-page: 44
  year: 2001
  ident: 308_CR16
  publication-title: Pediatr Neurol
  doi: 10.1016/S0887-8994(00)00230-7
– volume: 10
  start-page: 307
  year: 2006
  ident: 308_CR17
  publication-title: J AAPOS
  doi: 10.1016/j.jaapos.2006.02.004
– volume: 61
  start-page: 189
  year: 2007
  ident: 308_CR2
  publication-title: Ann Neurol
  doi: 10.1002/ana.21107
– volume: 25
  start-page: 295
  year: 1994
  ident: 308_CR4
  publication-title: Neuropediatrics
  doi: 10.1055/s-2008-1073043
– volume: 119
  start-page: 516
  year: 2001
  ident: 308_CR7
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.119.4.516
– volume: 47
  start-page: 4827
  year: 2006
  ident: 308_CR19
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.06-0327
– start-page: 1097
  volume-title: Ophthalmology
  year: 2004
  ident: 308_CR1
– volume: 14
  start-page: 790
  year: 2012
  ident: 308_CR15
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/nos076
– volume: 41
  start-page: 143
  year: 1997
  ident: 308_CR8
  publication-title: Ann Neurol
  doi: 10.1002/ana.410410204
– volume: 49
  start-page: 1879
  year: 2008
  ident: 308_CR20
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.07-1127
– volume: 125
  start-page: 63
  year: 1994
  ident: 308_CR3
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(94)70122-9
– volume: 12
  start-page: 89
  year: 1995
  ident: 308_CR18
  publication-title: Pediatr Neurol
  doi: 10.1016/0887-8994(95)90005-5
– volume: 37
  start-page: 90
  year: 2009
  ident: 308_CR10
  publication-title: Clin Exp Ophthalmol
  doi: 10.1111/j.1442-9071.2009.02015.x
– reference: 17697178 - Clin Exp Optom. 2007 Sep;90(5):317-35
– reference: 17065494 - Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4827-35
– reference: 17387725 - Ann Neurol. 2007 Mar;61(3):189-98
– reference: 19338607 - Clin Exp Ophthalmol. 2009 Jan;37(1):90-9
– reference: 8021787 - J Pediatr. 1994 Jul;125(1):63-6
– reference: 21232732 - Am J Ophthalmol. 2011 Mar;151(3):542-9.e2
– reference: 16935228 - J AAPOS. 2006 Aug;10(4):307-11
– reference: 19696668 - Curr Opin Ophthalmol. 2009 Nov;20(6):462-6
– reference: 16987732 - Lancet Neurol. 2006 Oct;5(10):853-63
– reference: 11182280 - Pediatr Neurol. 2001 Jan;24(1):44-8
– reference: 21857190 - J Neuroophthalmol. 2011 Sep;31(3):269-78
– reference: 22474213 - Neuro Oncol. 2012 Jun;14(6):790-7
– reference: 21168074 - J AAPOS. 2010 Dec;14(6):511-7
– reference: 7770126 - Neuropediatrics. 1994 Dec;25(6):295-300
– reference: 11292406 - Am J Ophthalmol. 2001 Apr;131(4):442-5
– reference: 7748370 - Pediatr Neurol. 1995 Jan;12(1):89-90
– reference: 7472822 - J Pediatr. 1995 Nov;127(5):718-22
– reference: 11296017 - Arch Ophthalmol. 2001 Apr;119(4):516-29
– reference: 16406539 - Ophthalmology. 2006 Feb;113(2):324-32
– reference: 18263812 - Invest Ophthalmol Vis Sci. 2008 May;49(5):1879-85
– reference: 9029062 - Ann Neurol. 1997 Feb;41(2):143-9
SSID ssj0004232
Score 2.10118
Snippet Purpose To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of...
To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those of healthy...
Purpose: To compare the optical coherence tomography (OCT) findings of neurofibromatosis-1 (NF-1) patients with/without optic pathway glioma (OPG) with those...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 172
SubjectTerms Adolescent
Child
Clinical Investigation
Female
Humans
Magnetic Resonance Imaging
Male
Medicine
Medicine & Public Health
Nerve Fibers - pathology
Neurofibromatosis 1 - diagnosis
Ophthalmology
Optic Nerve Glioma - diagnosis
Prospective Studies
Retina - pathology
Retinal Ganglion Cells - pathology
Tomography, Optical Coherence
Vision Disorders - diagnosis
Visual Acuity
Visual Fields
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS9xAEB7sCaUvRW2taVVW6FPLYrLJbvYeRFQUETxEFOxT2OwPECVR7_z_O5Ns7izSe8hLsgvDzuzMt5nZbwB-EiRQKhhuChF4IZzntdOBW6OUKIImAiKqtpio89vi4k7ercBkuAtDZZWDT-wctWst_SPfJya8MqOAfvj0zKlrFGVXhxYaJrZWcAcdxdgHWBXEjDWC1ePTydX14qakyCN_eMapucmQ5-wv0-WaKjLwyVPN1b-R6h38fJc67SLS2Rp8jlCSHfW6X4cV32zAx8uYLP8Cf95waLQNawOjG4s0paEyRxaoWIQ9GgTdjKreH8jrsfuGRa7VKaOftKxjvMSxLy2C23Z6P-XZV7g9O705OeexkwK3GG9mPHe1LYWyaWZtYRCTmaz2pRC1FDqkzjgvPZ5W8U1WSGPHweQSj6lBCoQ3mRH5JoyatvFbwDzGNReUC0GGQo5F7crSFDp4rcdBmjKBdFi1ykaacep28VgtCJJpoStc6IoWulIJ_JpPeeo5NpYN3h5UUcXtNq0WxpHA3vwzbhTKfpjGt6_dmBKdDyLOZWPoeKbGqUjgW6_muUSIg7RGk0ng96D3NwL8T9zvy8X9AZ9Eb3FoeNswmr28-h1EObN6N5ruXzLu91M
  priority: 102
  providerName: ProQuest
Title Investigation of retinal nerve fiber layer thickness in patients with neurofibromatosis-1
URI https://link.springer.com/article/10.1007/s10384-014-0308-6
https://www.ncbi.nlm.nih.gov/pubmed/24488155
https://www.proquest.com/docview/1506712183
https://www.proquest.com/docview/1507794835
https://www.proquest.com/docview/1543996902
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1613-2246
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0004232
  issn: 0021-5155
  databaseCode: AFBBN
  dateStart: 20040101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1613-2246
  dateEnd: 20190131
  omitProxy: true
  ssIdentifier: ssj0004232
  issn: 0021-5155
  databaseCode: 7X7
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1613-2246
  dateEnd: 20190131
  omitProxy: true
  ssIdentifier: ssj0004232
  issn: 0021-5155
  databaseCode: BENPR
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1613-2246
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0004232
  issn: 0021-5155
  databaseCode: AGYKE
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1613-2246
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0004232
  issn: 0021-5155
  databaseCode: U2A
  dateStart: 20040125
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WFspeSrutq_sRVNhTh8CWrY88piVZ2GgZo4Hkyci2BKHFLnX6__fOsZOUboE9GIN9MuLuJP3ku_sJ4BtBAqW85TYRnieicDwrjOe5VUok3hABEWVb3KnxJPk5ldO2jrvust27kGQzU28Uu8WGMibwikPD1Q7sSWLzQieeiMG6GFLELUV4xOn8ki6U-bdPvF2M3iHMd9HRZtEZHcJBixbZYGneI_jgyk-wf9vGwz_DbIMmoypZ5RkVJVKTkjIZmad8EPZoEVczSmx_oImNzUvW0qnWjP7DsobUEmWfK8SvVT2vefQFJqPh_c2Yt4cl8ByXlAWPiyzXQuVhlOeJRdhlo8xpITIpjA8LWzjpcEOKT6JE2rzvbSxxJ-qlQAQTWREfw25Zle4EmMOlq_Cq8F76RPZFVmhtE-OdMX0vrQ4g7LSW5i2TOB1o8ZiuOZBJ0SkqOiVFpyqAq1WTpyWNxjbh884UaTui6pSYEHVEgC6Ay9VrHAsU4LClq14aGY3zC4LKbTK0A1P9UATwdWnmVY8Q6hiDLhPA987uGx34V3dP_0v6DD6KpQOiH57D7uL5xV0grllkPdjRU92DvcGP2a8h3q-Hd7__9BrvfgWWnvFs
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VrQRcEG9CCxgJLiCLxHEc51AhHq22tF0h1ErllDqxLVVUSdtshfhz_DZmEme3qGJvPewl60jWeDzzTWbmG4DXBAmU8oYbKTyXwjpeWe15bZQS0msiIKJqi6maHMqvR9nRCvwZe2GorHK0ib2htm1N38jfExNenpBD_3B2zmlqFGVXxxEaJoxWsJs9xVho7Nh1v39hCNdt7nzB834jxPbWwecJD1MGeI22eMZTW9W5UHWc1LU0iFdMUrlciCoT2sfWWJc5jOTwSSIzUxfepBmGcD4T6PoTQ8QH6ALWZCoLDP7WPm1Nv31fdGaKNPCVJ5yGqYx51aF5L9VUAYK_NNZc_esZr8Hda6na3gNu34O7Abqyj4Ou3YcV1zyAW_shOf8Qflzh7Ggb1npGHZL0SkNllcxTcQo7NQjyGVXZ_yQry04aFrhdO0YfhVnPsIlrL1oE02130vHkERzeiEwfw2rTNu4pMId-1Hplvc-8zApR2Tw3UnundeEzk0cQj1Ir60BrTtM1TssFITMJukRBlyToUkXwdv7K2cDpsWzxxngUZbjeXblQxghezf_Gi0nZFtO49rJfk6OxQ4S7bA2Fg6qIRQRPhmOe7whxl9aoMhG8G8_9ygb-t91ny7f7Em5PDvb3yr2d6e463BGD9qESbsDq7OLSPUeENateBDVmcHzTN-cvKiozdg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT-QwDLZ4SIgLApZdyjMr7QkU0aZJmjkiYMRjF-1hR4JTlTaJhEAtosP_x562w6x4SBx6aZ0qsp3mS21_BvhFkEDrYLmVInApnOeFM4GXVmshgyECIsq2uNbnI3l5o266PqdNn-3ehyTbmgZiaarGR48uHM0UvqWGsifwSmPD9TwsSuJJQIceiePXwkiRdnThCadeJn1Y871X_L8xvUGbbyKlkw1ouAorHXJkx62p12DOV-uw9KeLjX-D2xnKjLpidWBUoEhDKspqZIFyQ9iDRYzNKMn9nj5y7K5iHbVqw-ifLJsQXKLsU41Ytm7uGp5swGh49u_knHeNE3iJ28uYp64oM6HLOClLaRGC2aTwmRCFEibEzjqvPB5O8U4ilS0HwaYKT6VBCUQziRXpd1io6spvAvO4jbmgXQgqSDUQhcsyK03wxgyCslkEca-1vOxYxam5xUP-yodMis5R0TkpOtcRHEyHPLaUGp8J7_SmyLvV1eTEipglBO4i-Dl9jOuCgh228vXzRCbDbw0CzM9k6DSmB7GI4Edr5umMEPYYgy4TwWFv95kJfDTdrS9J78PS39Nh_vvi-moblkXri-iSO7Awfnr2uwh3xsXexKVfADI59H8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Investigation+of+retinal+nerve+fiber+layer+thickness+in+patients+with+neurofibromatosis-1&rft.jtitle=Japanese+journal+of+ophthalmology&rft.au=Topcu-Yilmaz%2C+Pinar&rft.au=Kasim%2C+Burcu&rft.au=Kiratli%2C+Hayyam&rft.date=2014-03-01&rft.pub=Springer+Japan&rft.issn=0021-5155&rft.eissn=1613-2246&rft.volume=58&rft.issue=2&rft.spage=172&rft.epage=176&rft_id=info:doi/10.1007%2Fs10384-014-0308-6&rft.externalDocID=10_1007_s10384_014_0308_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5155&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5155&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5155&client=summon